biOasis/UCB sign research pact

biOasis Technologies has entered into a research collaboration agreement with UCB, to evaluate biOasis' Transcend technology in the delivery of therapeutic compounds to the brain. In connection with this agreement, biOasis will conduct certain experiments to provide UCB with confirmation of the Transcend technology as it relates to the delivery of therapeutic compounds owned by UCB, to the CNS. Financial terms of the agreement were not disclosed.

This article is tagged to:
Sector: Medical Devices
Geography: Belgium, Canada

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.